Arundhati Nag

USPTO Granted Patents = 11 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 45(Granted Patents)

Company Filing History:

9 out of 4,547

California Institute of Technology

where one patent can have more than one assignee

Years Active: 2014-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11719705 - IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making (2023-08-08),

2. 11371994 - Phosphorylated Akt-specific capture agents, compositions, and methods of using and making (2022-06-28),

3. 11365219 - Cyclic peptides as protein targeting agents (2022-06-21),

4. 11168115 - Cyclic peptides as protein targeting agents (2021-11-09),

5. 10913774 - Cyclic peptide binder against oncogenic K-Ras (2021-02-09),

6. 10598671 - IL-17F-specific capture agents, compositions, and methods of using and making (2020-03-24),

7. 10221214 - Akt-specific capture agents, compositions, and methods of using and making (2019-03-05),

8. 10017540 - Cyclic peptide binder against oncogenic K-Ras (2018-07-10),

9. 9239332 - Akt-specific capture agents, compositions, and methods of using and making (2016-01-19),

10. 9188584 - Capture agents and related compositions, methods and systems (2015-11-17),

11. 8906830 - Capture agents and related compositions, methods and systems (2014-12-09),

Title: Arundhati Nag: Innovator in Biochemical Detection Agents

Introduction

Arundhati Nag is a prominent inventor based in Pasadena, CA, known for her significant contributions to the field of biochemical detection agents. With a total of 11 patents to her name, she has made remarkable advancements in the development of capture agents that are crucial for medical diagnostics and treatment.

Latest Patents

Among her latest patents are the IL-17F and IL-17A-specific capture agents, compositions, and methods of using and making. This application provides stable peptide-based IL-17F and IL-17A capture agents and methods of use as detection agents. Additionally, it outlines methods for manufacturing IL-17F capture agents. Another notable patent is for phosphorylated Akt-specific capture agents, compositions, and methods of using and making. This application also provides stable peptide-based Akt capture agents and methods of use as detection and diagnosis agents, as well as in the treatment of diseases and disorders. It further details methods for manufacturing Akt capture agents using iterative on-bead in situ click chemistry.

Career Highlights

Arundhati has worked with esteemed organizations such as the California Institute of Technology and Indi Molecular, Inc. Her work in these institutions has allowed her to push the boundaries of innovation in her field.

Collaborations

Throughout her career, Arundhati has collaborated with notable individuals, including James R. Heath and Samir Das. These collaborations have contributed to her success and the advancement of her research.

Conclusion

Arundhati Nag is a trailblazer in the development of biochemical detection agents, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to impact the field of medical diagnostics and treatment.

This text is generated by artificial intelligence and may not be accurate.